Corrie Gidding
Radboud University Nijmegen
32 Papers
149 Citations
Corrie Gidding is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 11, co-authored 26 publications. Previous affiliations of Corrie Gidding include Radboud University Nijmegen Medical Centre.
Chat about Author
Papers
Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria
Marc H. A. Jansen,Sophie E. M. Veldhuijzen van Zanten,Esther Sanchez Aliaga,Martijn W. Heymans,Monika Warmuth-Metz,Darren Hargrave,Erica J. van der Hoeven,Corrie Gidding,Eveline S. J. M. de Bont,Omid S. Eshghi,Roel E. Reddingius,Cacha M. Peeters,Antoinette Y. N. Schouten-van Meeteren,Rob H. J. M. Gooskens,Bernd Granzen,Gabriel M. Paardekooper,Geert O. Janssens,David P. Noske,Frederik Barkhof,Christof M. Kramm,W. Peter Vandertop,Gertjan J.L. Kaspers,Dannis G. van Vuurden +22 more
TL;DR: A DIPG survival prediction tool that can be used to predict the outcome of patients and for stratification in trials is developed and validated by bootstrapping techniques.
213
Vincristine pharmacokinetics after repetitive dosing in children
Corrie Gidding,C.J. Meeuwsen-de Boer,Pauline Koopmans,Donald R. A. Uges,Willem Kamps,S.S.N. de Graaf +5 more
TL;DR: It is concluded that both intrapatient and interpatient variability in vincristine pharmacokinetics is large in pediatric cancer patients and that variability, although significantly influenced by diagnosis, largely remains unpredictable.
91
The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study.
Geert O. Janssens,Corrie Gidding,Erik J. van Lindert,Foppe Oldenburger,Corrie E. Erasmus,Antoinette Y.N. Schouten-Meeteren,Johannes H.A.M. Kaanders +6 more
TL;DR: This radical hypofractionation radiotherapy regimen for children with diffuse intrinsic brainstem glioma is feasible and associated with no Grade 3 or 4 toxicities, and with a minimal overall treatment time offers quick symptom relief and outcome results within the range of published data.
65
Psychosocial profile of pediatric brain tumor survivors with neurocognitive complaints.
Marieke A. de Ruiter,Antoinette Yvonne Narda Schouten-van Meeteren,Dannis G. van Vuurden,Heleen Maurice-Stam,Corrie Gidding,Laura Rachel Beek,Bernd Granzen,Jaap Oosterlaan,Martha A. Grootenhuis +8 more
TL;DR: PBTS with parent-reported neurocognitive complaints showed increased psychosocial problems, as reported by PBTS, parents, and teachers, andImplications for cancer survivorsSystematic screening of psychossocial functioning is necessary so that tailored support from professionals can be offered to PBTS with neuroc cognitive complaints.
•Journal Article
Real-time analysis of tyrosine hydroxylase gene expression: a sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma.
Lambert H.J. Lambooy,Corrie Gidding,Lambert P. van den Heuvel,Christina A. Hulsbergen-van de Kaa,Marjolijn J. L. Ligtenberg,Jos P.M. Bökkerink,Ronney A. De Abreu +6 more
TL;DR: The described tyrosine hydroxylase assay is specific, sensitive, and semiquantitative and can be used for the detection of neuroblastoma cell involvement in bone marrow and blood at diagnosis and during therapy and is a possible prognostic marker for Neuroblastoma.
40